Amgen (AMGN) PT Raised to $310 at Oppenheimer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- Goldman data shows hedge funds cut leverage at fastest pace since March
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $465.45 --0%
Rating Summary:
18 Buy, 20 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 15 | New: 12
Rating Summary:
18 Buy, 20 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 15 | New: 12
Join SI Premium – FREE
Oppenheimer analyst Jay Olson raised the price target on Amgen (NASDAQ: AMGN) to $310.00 (from $300.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Amgen (AMGN) call put ratio 1 call to 1 put with a focus on November 505 calls into quarter results
- Vertex (VRTX) PT Raised to $563 at Stifel
- Vitru Brasil Empreendimentos Participacoes (VTRU3:BZ) PT Lowered to R$15 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
